Risk of MS Activity After DMT Stop Greater With RRMS & 2-year Ocrevus Effective for Early MS episode artwork

EPISODE · Nov 2, 2022 · 13 MIN

Risk of MS Activity After DMT Stop Greater With RRMS & 2-year Ocrevus Effective for Early MS

from MS News & Perspectives · host MS News Today

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about a study showing that when MS patients stop their disease-modifying treatment, the risk of relapses and disease activity on MRI scans is higher among patients who have RRMS.He also reads an article on how Ocrevus safely and effectively reduced disease activity in people with early-stage relapsing-remitting multiple sclerosis.=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/=====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/

Episode metadata supplied by the publisher feed · Published Nov 2, 2022

Embed this episode

NOW PLAYING

Risk of MS Activity After DMT Stop Greater With RRMS & 2-year Ocrevus Effective for Early MS

0:00 13:56

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MS News & Perspectives?

This episode is 13 minutes long.

When was this MS News & Perspectives episode published?

This episode was published on November 2, 2022.

Can I download this MS News & Perspectives episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!